Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The blood tests may herald a new wave of noninvasive prenatal screening.
Mapping the genome of a fetus from its mother’s blood could mean less risky screening for prenatal diseases.
A DNA chip could make it easier to diagnose rare conditions while the patient is still in utero.
New technologies aim to reduce the risks and improve the accuracy of prenatal genetic tests.
A new blood test uses scraps of fetal DNA to piece together a prenatal diagnosis.